Explore Annogen’s insights
What Distinguishes Annogen In Gene Promoter Design?
What makes Annogen’s promoter design stand-out from other providers? A valid question. Let’s put this in historical context. Gene promoter design is nothing new: as early as the 1980’s, researchers began to understand different components within promoters, e.g. TATA...
Plant Animal Genomics PAG32 conference poster crop improvement
Download Poster Genome-Wide Functional Annotation of Regulatory Sequences, Identification of Gain-of-Function Variants in Plants, Animals Download the Annogen SuRE™ poster to learn how SuRE™ technology screens millions of gene regulatory elements (GREs) to identify...
Annogen’s FACE™: genome engineering roadmaps for crop improvement
A growing global population and a changing climate necessitates a more productive and resilient agricultural system, creating a challenge for crop breeders to improve crop resilience and productivity at an unprecedented pace.
Annogen’s AIM™ screen: bespoke expression locus identification for more effective cell therapies
Annogen’s AIM™ screen revolutionizes the level of control researchers have over transgene expression by identifying optimal genomic loci for transgene integration. Choosing the integration site with the right expression profile will enable safer and more effective cell and gene therapies.
SuRE™ promoter screening: customizing your therapy for improved safety and efficacy
The development of cell and gene therapies is a complex and time-consuming process that depends on therapeutic genes being expressed in the right tissues, at the right time and at the right dosage.
ISCT Europe – Poster hITA™
Explore how Annogen’s SuRE™ technology screens millions of gene regulatory elements to identify optimal promoters for T-cell activation, improving specificity and transgene expression.
ISCT Europe – Poster AIM™
Discover how Annogen’s AIM™ technology identifies precise genomic sites for controlled transgene expression, enhancing the safety and effectiveness of cell therapies.
Considerations for developing a safe and effective gene therapy
With more than 5,000 gene therapies in the clinic today [link], decades of promise finally seem to deliver treatments for dozens of rare diseases. Safety and effectiveness are however still major concerns, with short-lived and off-target expression being the main...
